Viewing Study NCT01887561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-02-25 @ 9:45 PM
Study NCT ID: NCT01887561
Status: UNKNOWN
Last Update Posted: 2013-06-27
First Post: 2013-04-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial
Sponsor: Kanto CML Study Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelogenous Leukemia, Chronic, Chronic Phase View
Keywords: